MARC record from Internet Archive

LEADER: 09381cam 2200721Ia 4500
001 ocn183030126
003 OCoLC
005 20200901183515.0
008 071207s2008 nyua b 001 0 eng d
010 $a 2007936052
040 $aCSG$beng$cCSG$dMUQ$dDLC$dOKH$dAU@$dYDXCP$dCRH$dORX$dDEBBG$dLML$dOCLCF$dOCLCQ$dUKM$dUKBOL$dOCLCQ$dZ5A$dSNN$dMAFCI$dOCLCQ$dOCLCO
015 $aGBA764284$2bnb
016 7 $a013818303$2Uk
019 $a233787203$a1049769166
020 $a1429206799$q(pbk.)
020 $a9781429206792$q(pbk.)
035 $a(OCoLC)183030126$z(OCoLC)233787203$z(OCoLC)1049769166
050 00 $aRM315$b.J75 2008
060 0 $aQV 77
082 04 $a615.788$222
084 $aCHE893f$2stub
084 $aMED941f$2stub
084 $aCZ 2000$2rvk
100 1 $aJulien, Robert M.
245 12 $aA primer of drug action :$ba comprehensive guide to the actions, uses, and side effects of psychoactive drugs /$cRobert M. Julien, Claire D. Advokat, and Joseph E. Comaty.
250 $a11th ed.
260 $aNew York :$bWorth Publishers,$c©2008.
300 $axiii, 729 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
505 0 $apt. 1. Introduction to psychopharmacology : how drugs interact with the body and the brain -- 1. Pharmacokinetics : how drugs are handled by the body -- Drug absorption -- Drug distribution -- Termination of drug action -- Time course of drug distribution and elimination : concept of drug half-life -- 2. Pharmacodynamics : how drugs act -- Receptors for drug action -- Dose-response relationships -- Drug safety and effectiveness -- 3. The neuron, synaptic transmission, and neurotransmitters -- Overall organization of the brain -- The neuron -- Specific neurotransmitters.
505 0 $apt. 2. Drugs that depress brain function : sedative-hypnotic drugs -- 4. Ethyl alcohol and the inhalants of abuse -- Ethyl alcohol -- Pharmacology of alcohol -- Tolerance and dependence -- Side effects and toxicity -- Teratogenic effects -- Alcoholism and its pharmacological treatment -- Inhalants of abuse -- Why inhalants are abused and who abuses them -- Medical consequences of inhalant abuse -- Acute intoxication and chronic effects -- Chapter 4 appendix : what is a drink? How much alcohol is in my drink? -- 5. Barbiturates, general anesthetics, gamma hydroxybutyrate (GHB), and antiepileptic drugs -- Historical background -- Sites and mechanisms of action -- Sedative-induced brain dysfunction -- Specific depressants -- Barbiturates -- Nonbarbiturate sedative-hypnotic drugs -- General anesthetics -- Gamma hydroxybutyrate -- Antiepileptic drugs -- Relationships between structure and activity -- Specific agents -- Antiepileptic drugs in pregnancy -- 6. Benzodiazepines and related anxiolytic medications -- Benzodiazepines -- Flumazenil : a benzodiazepine receptor agonist -- Benzodiazepine receptor agonist hypnotics -- Ramelteon : a selective melatonin receptor agonist -- Serotonin receptor agonists as anxiolytics -- Anticonvulsants as anxiolytics.
505 0 $apt. 3. Drugs that are used to treat psychological disorders -- 7. Antidepressant drugs -- Depression -- First-generation and antidepressants -- Second-generation antidepressants -- Selective serotonin reuptake inhibitors -- Dual-action antidepressants -- Dopamine-norepinephrine reuptake inhibitor : bupropion -- Selective norepinephrine reuptake inhibitors -- STAR*D study -- Antidepressants of the future -- 8. Drugs used to treat bipolar disorder -- Bipolar disorder -- STEP-BD study -- Lithium -- "Neuromodulator" anticonvulsant mood stabilizers -- Other uses for anticonvulsant mood stabilizers -- Atypical antipsychotics -- Omega-3 fatty acids -- Miscellaneous agents -- Psychotherapeutic and psychosocial treatments -- 9. Antipsychotic drugs -- Schizophrenia -- Historical background and classification of antipsychotic drugs -- CATIE and CUtLASS studies -- First-generation antipsychotic drugs : phenothiazines -- Alternative first-generation antipsychotics -- Second-generation (atypical) antipsychotic drugs -- Prominent side effects of second-generation antipsychotics -- Additional applications for second-generation antipsychotics -- 10. Child and adolescent psychopharmacology -- Behavioral and aggressive disorders -- Autism spectrum disorders -- Attention deficit/hyperactivity disorder -- Depression in children and adolescents -- Anxiety disorders in children and adolescents -- Bipolar disorder in children and adolescents -- Psychotic disorders in children and adolescents -- 11. Geriatric psychopharmacology -- Inappropriate drug use in the elderly -- Control of agitated and aggressive behaviors in the elderly -- Undertreatment of the elderly : focus on depression -- Parkinson's disease -- Alzheimer's disease -- 12. Integrating psychopharmacology and psychological therapies in patient care -- Limitations to pharmacological therapy -- Developing a plan to integrate psychopharmacology and psychological therapies -- Clinical examples -- Limitations to current practice -- Examples of areas of needed involvement -- Chapter 12 appendix : quick reference to psychotropic medication.
505 0 $apt. 4. Drugs that stimulate brain function : psychostimulants -- 13. Cocaine, the amphetamines, and nonamphetamine behavioral stimulants -- Cocaine -- Forms of cocaine -- Pharmacokinetics -- Mechanism of action -- Pharmacological effects in human beings -- Comorbidity -- Cocaine and pregnancy -- Neurotoxicity of cocaine -- Pharmacological treatment of cocaine dependency -- Novel approaches to the treatment of cocaine addiction -- Amphetamines -- Mechanism of action -- Pharmacological effects -- Dependence and tolerance -- Methamphetamine -- Nonamphetamine behavioral stimulants -- 14. Caffeine and nicotine -- Caffeine -- Pharmacokinetics -- Pharmacological effects -- Mechanism of action -- Reproductive effects -- Tolerance and dependence -- Nicotine -- Pharmacokinetics -- Pharmacological effects -- Mechanism of action -- Tolerance and dependence -- Toxicity -- Effects of passive smoke -- Effects during pregnancy -- Therapy for nicotine dependence.
505 0 $apt. 5. Analgesic drugs and psychedelics -- 15. Nonnarcotic anti-inflammatory analgesics -- Nonselective cyclooxygenase inhibitors -- Selective COX-2 inhibitors -- Nonopioid analgesics of the future : nitric oxide-donating analgesics -- 16. Opioid analgesics -- History -- Terminology -- Opioid receptors -- Classification of opioid analgesics -- Morphine : a pure opioid agonist -- Other pure opioid agonists -- Partial opioid agonists -- Mixed agonist-antagonist opioids -- Pure opioid antagonists -- Opioid combinations -- Pharmacotherapy of opioid dependence -- 17. Cannabinoid agonists and antagonists -- History -- Mechanism of action : cannabinoid receptor -- Pharmacokinetics -- Pharmacological effects -- Tolerance and dependence -- Therapeutic uses of cannabinoid agonists -- Cannabinoid antagonists -- 19 Psychedelic drugs -- Scopolamine : an anticholinergic psychedelic/catecholaminelike psychedelics -- Serotoninlike psychedelics -- Glutaminergic NMDA receptor antagonists -- Salvinorin A.
505 0 $apt. 6. Special topics in psychopharmacology -- 19. Herbal medicines for psychological disorders -- St. John's Wort -- Ginkgo -- Kava -- Ephedrine (Ma-Huang) -- Other herbals that act on the CNS -- Conclusions -- 20. Anabolic steroids -- Mechanism of action -- Effects -- Side effects -- Physical dependence -- Abuse and treatment -- 21. Topics in drug abuse -- Historical and current perspectives -- Extent of the drug problem -- Nosology and psychopathology of substance abuse -- Drugs as behavioral reinforcers : neurobiology of drug dependence -- Drug availability -- Addiction as a chronic, relapsing illness -- Drug education -- Treatment issues -- Pharmacotherapy of substance use disorders -- Glossary.
520 $aAddresses the mechanisms of action of each drug and drug class presented, current theories about the etiology of major psychological disorders and rationales for drug treatment, as well as the uses and limitations of psychopharmacology in patient care.
650 0 $aPsychotropic drugs.
650 0 $aPsychopharmacology.
650 2 $aPsychotropic Drugs$xtherapeutic use.
650 2 $aPsychotropic Drugs$xpharmacology.
650 6 $aPsychotropes.
650 6 $aPsychopharmacologie.
650 7 $aPsychopharmacology.$2fast$0(OCoLC)fst01081659
650 7 $aPsychotropic drugs.$2fast$0(OCoLC)fst01081826
650 7 $aWirkung$2gnd
650 7 $aPsychopharmakon$2gnd
650 7 $aPsychopharmakologie$2gnd
700 1 $aAdvokat, Claire D.
700 1 $aComaty, Joseph E.
856 41 $3Table of contents$uhttp://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&doc_number=016992525&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
856 4 $uhttp://www.gbv.de/dms/bs/toc/566274779.pdf$zlizenzfrei
938 $aYBP Library Services$bYANK$n100479444
029 1 $aAU@$b000042806376
029 1 $aCHSGL$b001055973
029 1 $aCHVBK$b051425947
029 1 $aDEBBG$bBV035185837
029 1 $aNZ1$b12237512
029 1 $aNZ1$b12526008
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 151 OTHER HOLDINGS